Treatment Strategy and Symptom Management

Because the C9ORF72 expansion affects movement, behavior, and motor neurons, there is currently no single disease-modifying cure for the condition. Instead, care is multidisciplinary—meaning a team of different specialists works together to manage your specific symptoms ^[1][2].

The goal of treatment is to improve your quality of life by balancing the benefits of a medication against its potential side effects on other parts of the disease spectrum.

Urgent Warning Signs

Contact your care team promptly or seek emergency care if you experience:

• Psychiatric crises: New or worsening depression, or any suicidal thoughts.
• Severe respiratory changes: New breathlessness, inability to breathe while lying flat (orthopnea), severe morning headaches, or excessive daytime sleepiness.
• Swallowing emergencies: Repeated choking, inability to handle your own saliva, or a sudden, severe change in speech.
• Severe sedation or recurrent falls.

Domain 1: Managing Huntington’s-Like Movement

When chorea (involuntary, jerky movements) becomes bothersome or dangerous—for example, if it causes falls or prevents you from eating—doctors may consider symptom-directed medications that were originally developed for classic Huntington’s disease, though their use here is largely off-label and extrapolated from Huntington’s evidence ^[3].

• VMAT2 Inhibitors: Medications like deutetrabenazine, tetrabenazine, or valbenazine work by reducing the amount of dopamine in the brain to “calm” the movements ^[3][4]. In clinical trials for classic Huntington’s, deutetrabenazine significantly improved chorea scores, but regulatory approval for Huntington’s does not establish efficacy specifically for C9ORF72 ^[5]. These medications require careful monitoring, as they carry warnings for causing or worsening depression and suicidal thinking.
• Antipsychotics: These are sometimes used off-label if you have both chorea and significant behavioral changes (like agitation or delusions) ^[6].
• The Trade-off: Any medication that blocks dopamine can cause parkinsonism (muscle stiffness and slowness) or somnolence (excessive sleepiness), which may increase your risk of falling or make it harder to swallow safely ^[7][8]. Antipsychotics also carry important warnings in people with dementia-related syndromes and can increase metabolic or cardiovascular risks.

Domain 2: Managing FTD-Like Behavioral Symptoms

Behavioral changes are often the most challenging part of the C9ORF72 spectrum for families. Management involves both medication and changes to your environment ^[9][10].

• Psychosis and Agitation: If you experience hallucinations or delusions, your doctor may consider low doses of antipsychotic medications, weighing the significant risks mentioned above ^[9].
• Apathy: This deep loss of motivation is very common in the C9ORF72 spectrum. Non-medication strategies—like keeping a strict daily routine and using “external cues” (timers or checklists)—are often more effective than pills ^[11][12].
• Caregiver Support: Because these symptoms are stressful, psychoeducation for your family is a core part of treatment. Learning why these behaviors happen can help reduce caregiver burden ^[10].

Domain 3: Managing ALS-Like Respiratory and Swallowing Issues

Because this expansion can affect the muscles used for breathing and swallowing (bulbar symptoms), proactive monitoring is vital ^[13][14].

• Swallowing (Dysphagia): You should have evaluations by a Speech-Language Pathologist (SLP) when indicated by clinical symptoms like weight loss or coughing during meals. They can recommend individualized compensatory techniques, posture changes, or texture modifications to help manage aspiration, which is when food or liquid accidentally enters the lungs ^[15][16]. Note that thickened liquids do not prevent aspiration in all cases and are not appropriate for everyone.
• Breathing (Respiratory): Your medical team will monitor your lung function based on ALS evidence, which may include tests like Forced Vital Capacity (FVC), SNIP, cough strength, or nocturnal oximetry, though a normal FVC does not exclude nighttime breathing issues ^[17].
• Respiratory Support: If your breathing muscles weaken, Non-invasive Ventilation (NIV)—such as a BiPAP machine used at night—can improve your sleep quality and energy levels ^[2][17]. Evidence that it improves overall survival is largely extrapolated from ALS populations.

Your Multidisciplinary Care Team

Building a strong “home base” for your care is essential. A typical team for a C9ORF72 HD-like syndrome includes:

• Movement Disorder Neurologist: To manage chorea and parkinsonism.
• Neuromuscular Specialist: To monitor for ALS-like muscle and breathing changes.
• Psychiatrist or Behavioral Neurologist: To help with mood, personality, and thinking shifts.
• Speech-Language Pathologist: To evaluate swallowing and communication.
• Pulmonologist: To oversee respiratory health and NIV.
• Social Worker or Counselor: To provide emotional support and navigate the complex healthcare system.